| 1 |
34632049 | Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation. | 2021 Dec 17 |
4 |
| 2 |
31293656 | Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients. | 2019 |
1 |
| 3 |
30103710 | CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy. | 2018 Aug 13 |
5 |
| 4 |
26110425 | Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome. | 2015 |
17 |
| 5 |
23256041 | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1. | 2012 Dec 18 |
7 |
| 6 |
23256047 | How does doxorubicin work? | 2012 Dec 18 |
1 |